Tumor cells must attach themselves to basement membranes, through which they degrade and migrate, in order to spread to distant sites. If vascular endothelial cells are damaged by pretreatment with anticancer drugs and the subendothelial basement membranes are exposed, the attachment of malignant cells to basement membranes and subsequent metastasis formation in some tissues may be enhanced. In this study, the pretreatment of endothelial cell monolayers and mice with cyclophosphamide (CPA) was respectively shown to promote the adhesion of HT1080 human fibrosarcoma cells to endothelial cell monolayersin vitro and lung colonizationin vivo. YIGSR, a synthetic laminin pentapeptide, inhibited the enhancement of lung colonization by CPA when it was co-injected intravenously with tumor cells. This inhibitory effect of YIGSR may be due to a reduction in the adhesion of HT1080 cells to injured blood vessel walls since YIGSR inhibited both the adhesion of HT 1080 cells to CPA-treated endothelial cell monolayers and the invasion through basement membranesin vitro.
Similar content being viewed by others
References
Martin GR and Timpl R, 1987, Laminin and other basement membrane components.Annual Review of Cell Biology,3, 57–85.
Engel J, Odermatt E, Engel A, Furthmayr H, Rohde MM and Timpl R, 1981, Shapes, domain organizations and flexibility of laminin and fibronectin, two multifunctional proteins of the extracellular matrix.Journal of Molecular Biology,150, 97–120.
Sasaki M, Kato S, Kohno K, Martin GR and Yamada Y, 1987, Sequence of cDNA encoding the mouse laminin 131 chain reveals a multidomain protein containing cysteine-rich repeat.Proceedings of the National Academy of Sciences, USA,84, 935–939.
Sasaki M and Yamada Y, 1987, The laminin 132 chain has a multidomain structure homologous to the B1 chain.Journal of Biological Chemistry,262, 17,111–17,117.
Sasaki M, Kleinman HK, Huber H, Deutzmann R and Yamada Y, 1988, Laminin, a multi-domain protein: the A chain has a unique globular domain and is homologous with the basement heparan proteoglycan and the laminin B chains.Journal of Biological Chemistry,263, 16536–16544.
Graf J, Yamada Y, Robey FA, Sasaki M, Ogle RC, Kleinman HK and Martin GR, 1987, A pentapeptide from the laminin B1 chain mediates cell adhesion and binds the Mr = 67000 laminin receptor.Biochemistry,26, 6896–6900.
Iwamoto Y, Robey FA, Graf J, Sasaki M, Kleinman HK, Yamada Y and Martin GR, 1987, YIGSR, a synthetic laminin pentapeptide, inhibits experimental metastasis formation.Science,238, 1132–1134.
Liotta LA, 1984, Tumor invasion and metastasis: role of the basement membrane.American Journal of Pathology,117, 339–348.
Roose E and Dingemans KP, 1979, Mechanism of metastasis.Biochimica et Biophysica Acta,560, 135–166.
Kramer RM, Gonzalez R and Nicolson GL, 1980, Metastatic tumor cells adhere preferentially to the extracellular matrix underlying vascular endothelial cells.International Journal of Cancer,26, 639–645.
Takamizawa A, Matsumoto S, Iwata T, Tachino Y, Katagiri K, Yamaguchi K and Shiratori O, 1975, Study on cyclophosphamide metabolites and their related compounds. 2. Preparation of an active species of cyclophosphamide and compounds.Journal of Medical Chemistry,18, 376–383.
Rasheed S, Nelson-Rees WA, Toth EM, Araskin P and Gardner MB, 1974, Characterization of a newly derived human sarcoma cell line.Cancer,33, 1027–1033.
Nakashima Y, Sueishi K and Tanaka K, 1988, Thrombin enhances production and release of tissue plasminogen activator from bovine venous endothelial cells.Fibrinolysis,2, 227–234.
Voldavsky I, Ariav Y, Atzmon R and Fukus Z, 1982, Tumor cell attachment to the vascular endothelium and subsequent degradation of the sub-endothelial extracellular matrix.Experimental Cell Research,140, 149–159.
Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM and McEwan RN, 1987, A rapid in vitro assay for quantitating the invasive potential of tumor cells.Cancer Research,47, 3239–3245.
Kleinman HK, McGarvey ML, Hassel JR, Star VL, Cannon FB, Lauise GW and Martin GR, 1986, Basement membrane complexes with biological activity.Biochemistry,25, 312–318.
Carmel RJ and Brown JM, 1977, The effect of cyclophosphamide and other drugs on the incidence of pulmonary metastasis in mice.Cancer Research,37, 145–151.
de Ruiter J, Smink T and van Putten LM, 1976, Studies on the enhancement by cyclophosphamide (NSC-26271) of artificial lung metastasis after labelled cell inoculation.Cancer Treatment Report,60, 465–470.
Milas L, Malenica B and Allegretti N, 1979, Enhancement of artificial lung metastasis in mice caused by cyclophosphamide.Cancer Immunology and Immunotherapy,6, 191–196.
Rosen G, Caparros B, Huvos GA, Kosloff C, Nienberg RNA, Cacavio A, Marcove CR and Lane MJ, 1982, Preoperative chemotherapy for osteogenic sar coma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy.Cancer,49, 1221–1230.
Rouss JG, Friemann F, Sevin MD, Chevalier LT and Spielman LM, 1987, Preoperative induction chemotherapy in the treatment of locally advanced soft tissue sarcomas.Cancer,60, 296–300.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Iwamoto, Y., Fujita, Y. & Sugioka, Y. YIGSR, a synthetic laminin peptide, inhibits the enhancement by cyclophosphamide of experimental lung metastasis of human fibrosarcoma cells. Clin Exp Metast 10, 183–189 (1992). https://doi.org/10.1007/BF00132750
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00132750